SHSE:600361
SHSE:600361Metals and Mining

Asian Penny Stocks To Watch In January 2026

As the Asian markets continue to navigate a landscape shaped by evolving trade dynamics and economic policies, investors are increasingly exploring diverse opportunities within the region. Penny stocks, often representing smaller or newer companies, remain an intriguing investment area despite their somewhat outdated name. These stocks can offer surprising value and growth potential when backed by strong financial foundations and solid fundamentals.
SHSE:600610
SHSE:600610Chemicals

Exploring 3 Undiscovered Gems in Asia with Promising Potential

As global markets experience mixed performance, with small-cap and value stocks leading gains over large-cap counterparts, attention turns to Asia where emerging opportunities may lie. In this dynamic landscape, identifying promising stocks often involves looking for companies that demonstrate resilience and adaptability in the face of evolving market conditions.
TSE:1946
TSE:1946Construction

Asian Dividend Stocks: 3 Top Picks For Your Portfolio

As the Asian markets navigate a landscape marked by regulatory changes in China and political developments in Japan, investors are increasingly focused on stable income opportunities amidst fluctuating indices. In this environment, dividend stocks stand out as appealing options for those seeking consistent returns, providing a buffer against market volatility while capitalizing on Asia's diverse economic backdrop.
TSE:8966
TSE:8966REITs

Heiwa Real Estate REIT (TSE:8966) Forecast Earnings Decline Tests Bullish Growth Narrative

Heiwa Real Estate REIT H1 2026 Earnings Snapshot Heiwa Real Estate REIT (TSE:8966) has reported revenue of ¥10.7 billion and basic EPS of ¥4,161.77 for H1 2026, with trailing twelve month revenue of ¥20.9 billion and EPS of ¥8,247.03 providing context for the latest run rate. The trust’s revenue has moved from ¥9.0 billion and EPS of ¥3,431.65 in H1 2025 to ¥10.2 billion and ¥4,083.25 in H2 2025, then to the current H1 2026 levels. This progression gives investors a clearer view of how income...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Assessing Alvotech (ALVO) Valuation After FDA Setback And Securities Investigation Concerns

What triggered the sharp move in Alvotech? Alvotech (ALVO) shares fell sharply after reports of potential securities claims tied to allegedly misleading business information, together with an FDA complete response letter citing deficiencies at the company’s Reykjavik manufacturing facility. See our latest analysis for Alvotech. Those legal and regulatory setbacks land on top of a weak backdrop, with a 90 day share price return of a 39.73% decline and a 1 year total shareholder return of a...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Why Constellation Energy (CEG) Is Down 11.4% After PJM Price Caps and Auction Reforms - And What's Next

The Trump administration, working with Mid-Atlantic governors, recently moved to impose price caps and push emergency auctions in the PJM power grid, raising questions about how Constellation Energy can monetize its large nuclear and gas generation portfolio in that region. An underappreciated angle is that while the policy may restrict pricing on existing plants, it could also channel long-term contracts toward new Constellation-backed capacity builds. We’ll now examine how these new PJM...
NYSE:DGX
NYSE:DGXHealthcare

Quest Diagnostics Expands At Home STI Testing As Valuation Signals Upside Potential

Quest Diagnostics (NYSE:DGX) has partnered with Visby Medical to offer an at-home, FDA authorized PCR test focused on women's sexual health. The new test targets common STIs and is available directly through Quest's consumer-initiated testing platform. This move aims to reduce access barriers for STI screening and aligns with broader demand for convenient, at-home diagnostics. For investors watching NYSE:DGX, this new offering adds another consumer-focused service on top of an existing...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Halozyme Takeda ENHANZE Deal Links Growth Potential With Valuation Upside

Halozyme Therapeutics (NasdaqGS:HALO) has signed a global collaboration and exclusive license agreement with Takeda. The deal gives Takeda access to Halozyme's ENHANZE drug delivery technology for use with vedolizumab. Vedolizumab is used in the treatment of Crohn's disease and ulcerative colitis. The agreement includes upfront, milestone, and royalty payments to Halozyme. For you as an investor, this agreement ties Halozyme's ENHANZE platform directly to a globally marketed...
XTRA:SIE
XTRA:SIEIndustrials

Siemens (XTRA:SIE) Valuation Check After Recent Pullback And Strong Multi Year Shareholder Returns

Siemens (XTRA:SIE) has been drawing fresh attention after recent share price moves, with the stock down about 0.9% over the past day and 3.1% over the past week, yet still positive over the month. See our latest analysis for Siemens. Set against that short term pullback, Siemens has a 1 year total shareholder return of 27.18% and a 3 year total shareholder return of 91.8%. The latest share price of €253.7 sits on gains that have cooled slightly in recent weeks, which hints that momentum is...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex Pharmaceuticals (VRTX) Valuation After Analyst Upgrades And Cystic Fibrosis Growth Story

Recent analyst moves have put Vertex Pharmaceuticals (VRTX) back in focus, with Bernstein upgrading the stock and UBS initiating coverage. Both firms point to cystic fibrosis strength and upcoming 2026 to 2027 data readouts. See our latest analysis for Vertex Pharmaceuticals. Vertex shares now trade at US$442.08, with a softer 30 day share price return of a 3.1% decline and a year to date share price return of a 2.2% decline, contrasting with a 5 year total shareholder return of 86.03%. This...
TSX:TKO
TSX:TKOMetals and Mining

Assessing Taseko Mines (TSX:TKO) Valuation After Florence Copper Completion And Gibraltar Production Update

Why Florence Copper and Gibraltar Matter for Taseko Mines (TSX:TKO) Taseko Mines (TSX:TKO) has drawn fresh attention after completing construction at Florence Copper and reporting 2025 production figures from its Gibraltar Mine, highlighting progress across both its growth project and operating asset. See our latest analysis for Taseko Mines. These Florence and Gibraltar updates land after a strong run in the shares, with a 30 day share price return of 30.46%, a 90 day share price return of...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Marriott Leadership Shakeup Tests Growth Story And Regional Execution

Marriott International (NasdaqGS:MAR) has announced major leadership changes, including the retirement of two long-serving executives. New regional presidents have been appointed to oversee key geographies, signaling a shift in how the company is organizing its global oversight. These appointments are intended to refresh leadership across regions that are central to Marriott's growth plans and operational focus. For investors tracking Marriott International, the leadership reshuffle comes...
NYSE:HPQ
NYSE:HPQTech

Assessing HP (HPQ) Valuation After Recent Share Price Weakness

Why HP (HPQ) is on investors’ radar now HP (HPQ) has seen its share price under pressure recently, with negative returns over the past month and past 3 months, prompting some investors to reassess how the current price lines up with fundamentals. See our latest analysis for HP. Looking beyond the recent weakness, HP’s latest share price of $19.80 sits alongside a 1 month share price return of 14.88% and a 1 year total shareholder return of 37.24% in the red, suggesting momentum has been...
NYSE:NIO
NYSE:NIOAuto

Nio’s AI Push and ES8 Sales Surge Could Be A Game Changer For NIO (NIO)

Nio has recently ramped up its commitment to artificial intelligence across its operations while its third-generation ES8 SUV hit rapid delivery milestones and topped China’s large SUV sales rankings in December. Together, the AI push and ES8 momentum suggest Nio is trying to sharpen both its technology edge and its core vehicle franchise at the same time. We’ll now examine how Nio’s intensified AI investment program could influence the company’s broader investment narrative and long-term...